The safety of ranitidine in children has been a topic of discussion, especially given recent findings regarding its potential contamination with N-nitrosodimethylamine (NDMA), a probable human carcinogen. Previously, ranitidine was widely prescribed for pediatric patients with conditions like GERD and acid reflux. However, due to concerns about NDMA contamination, the FDA has recommended that all ranitidine products be withdrawn from the market.
